ME

Share with:

Medd AI

📄 Text Summarization 📈 Data Analysis 💡 Business Intelligence 🔬 Research Discontinued · Feb 13, 2026

Last updated:

Medd AI is an advanced AI platform designed to significantly accelerate biomedical research and scientific discovery. It empowers researchers, scientists, and R&D teams in pharma and biotech to rapidly find, analyze, and synthesize vast amounts of scientific knowledge. By leveraging AI-powered insights, Medd AI streamlines literature reviews, identifies critical connections, and fosters the generation of novel hypotheses, ultimately driving breakthroughs faster than traditional methods.

biomedical research ai insights drug discovery scientific literature knowledge graph nlp biotech pharma r&d data analysis hypothesis generation
4 views 0 comments Published: Aug 18, 2026 United States, US, USA, Northern America, North America

Why was this tool discontinued?

Automatically marked inactive after 7 consecutive failed health checks (last error: Connection timeout)

What It Does

The platform functions by ingesting and semantically analyzing a comprehensive array of scientific literature, including PubMed, clinical trials, patents, and grants. It then extracts key entities and relationships, performs sentiment and trend analysis, and utilizes AI to summarize complex information. This enables users to answer specific research questions, identify gaps in knowledge, and generate new hypotheses with unprecedented speed and accuracy.

Pricing

Pricing Type: Paid
Pricing Model: Paid

Pricing Plans

Enterprise Solution
Custom

Tailored solutions for large pharmaceutical companies, biotech firms, and research institutions with specific integration and scale requirements. Contact sales for a personalized quote.

  • Full platform access
  • Dedicated support
  • Custom integrations
  • Scalable usage
  • Advanced analytics

Core Value Propositions

Accelerated Research Cycles

Significantly shortens the time required for literature review, data analysis, and hypothesis generation, speeding up research pipelines.

Enhanced Discovery Potential

Uncovers non-obvious connections and generates novel hypotheses, leading to breakthrough discoveries that might otherwise be missed.

Improved Decision Making

Provides comprehensive, AI-powered insights for more informed strategic decisions in R&D, target identification, and clinical development.

Competitive Intelligence Advantage

Offers real-time trend analysis and competitive landscaping, allowing organizations to stay ahead in fast-evolving scientific fields.

Use Cases

Drug Target Identification

Identify promising new drug targets by analyzing vast datasets of genetic, proteomic, and disease-related information, accelerating preclinical research.

Systematic Literature Reviews

Conduct comprehensive and unbiased systematic reviews for academic publications, grant proposals, or regulatory filings with AI-driven efficiency.

Clinical Trial Design Optimization

Enhance clinical trial design by identifying optimal patient cohorts, biomarkers, and potential adverse events through deep literature analysis.

Competitive R&D Intelligence

Monitor competitor activities, emerging technologies, and intellectual property landscapes to inform strategic R&D decisions and market positioning.

Biomarker Discovery

Accelerate the discovery and validation of novel biomarkers for disease diagnosis, prognosis, and therapeutic response prediction.

Hypothesis Generation for Grants

Generate strong, data-backed hypotheses for grant applications, increasing the likelihood of funding and driving innovative research projects.

Technical Features & Integration

Semantic Search Engine

Enables precise and context-aware searching across a vast scientific corpus, far beyond keyword matching, to find highly relevant information quickly.

AI-powered Knowledge Graph

Automatically constructs and visualizes relationships between biomedical entities (e.g., genes, proteins, diseases, drugs), revealing hidden connections and insights.

Intelligent Summarization

Generates concise, accurate summaries of scientific papers and documents, allowing researchers to grasp key findings without reading full texts.

Trend & Gap Analysis

Identifies emerging research trends, key opinion leaders, and significant gaps in existing knowledge, crucial for strategic planning and innovation.

Hypothesis Generation

Leverages AI to suggest novel hypotheses and research directions by synthesizing information from disparate sources, accelerating discovery pipelines.

Comprehensive Data Ingestion

Integrates and analyzes data from diverse sources including PubMed, clinical trials, patents, and grants, ensuring a holistic view of the scientific landscape.

Customizable Dashboards

Provides personalized views and analytics, allowing users to track specific research areas, competitors, or project progress efficiently.

Target Audience

Medd AI is primarily designed for biomedical researchers, scientists, R&D teams within pharmaceutical and biotechnology companies, and academic institutions. It is invaluable for roles involved in drug discovery, preclinical research, clinical development, competitive intelligence, and grant writing.

Frequently Asked Questions

Medd AI is a paid tool. Available plans include: Enterprise Solution.

The platform functions by ingesting and semantically analyzing a comprehensive array of scientific literature, including PubMed, clinical trials, patents, and grants. It then extracts key entities and relationships, performs sentiment and trend analysis, and utilizes AI to summarize complex information. This enables users to answer specific research questions, identify gaps in knowledge, and generate new hypotheses with unprecedented speed and accuracy.

Key features of Medd AI include: Semantic Search Engine: Enables precise and context-aware searching across a vast scientific corpus, far beyond keyword matching, to find highly relevant information quickly.. AI-powered Knowledge Graph: Automatically constructs and visualizes relationships between biomedical entities (e.g., genes, proteins, diseases, drugs), revealing hidden connections and insights.. Intelligent Summarization: Generates concise, accurate summaries of scientific papers and documents, allowing researchers to grasp key findings without reading full texts.. Trend & Gap Analysis: Identifies emerging research trends, key opinion leaders, and significant gaps in existing knowledge, crucial for strategic planning and innovation.. Hypothesis Generation: Leverages AI to suggest novel hypotheses and research directions by synthesizing information from disparate sources, accelerating discovery pipelines.. Comprehensive Data Ingestion: Integrates and analyzes data from diverse sources including PubMed, clinical trials, patents, and grants, ensuring a holistic view of the scientific landscape.. Customizable Dashboards: Provides personalized views and analytics, allowing users to track specific research areas, competitors, or project progress efficiently..

Medd AI is best suited for Medd AI is primarily designed for biomedical researchers, scientists, R&D teams within pharmaceutical and biotechnology companies, and academic institutions. It is invaluable for roles involved in drug discovery, preclinical research, clinical development, competitive intelligence, and grant writing..

Significantly shortens the time required for literature review, data analysis, and hypothesis generation, speeding up research pipelines.

Uncovers non-obvious connections and generates novel hypotheses, leading to breakthrough discoveries that might otherwise be missed.

Provides comprehensive, AI-powered insights for more informed strategic decisions in R&D, target identification, and clinical development.

Offers real-time trend analysis and competitive landscaping, allowing organizations to stay ahead in fast-evolving scientific fields.

Identify promising new drug targets by analyzing vast datasets of genetic, proteomic, and disease-related information, accelerating preclinical research.

Conduct comprehensive and unbiased systematic reviews for academic publications, grant proposals, or regulatory filings with AI-driven efficiency.

Enhance clinical trial design by identifying optimal patient cohorts, biomarkers, and potential adverse events through deep literature analysis.

Monitor competitor activities, emerging technologies, and intellectual property landscapes to inform strategic R&D decisions and market positioning.

Accelerate the discovery and validation of novel biomarkers for disease diagnosis, prognosis, and therapeutic response prediction.

Generate strong, data-backed hypotheses for grant applications, increasing the likelihood of funding and driving innovative research projects.

Reviews

Sign in to write a review.

No reviews yet. Be the first to review this tool!

Related Tools

View all alternatives →

Get new AI tools weekly

Join readers discovering the best AI tools every week.

You're subscribed!

Comments (0)

Sign in to add a comment.

No comments yet. Start the conversation!